0001209191-20-062809.txt : 20201210 0001209191-20-062809.hdr.sgml : 20201210 20201210202444 ACCESSION NUMBER: 0001209191-20-062809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY MARY ANN CENTRAL INDEX KEY: 0001261974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 201381955 MAIL ADDRESS: STREET 1: 201 W 70TH ST, SUITE 23K CITY: NEW YORK STATE: NY ZIP: 10023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001261974 GRAY MARY ANN 215 FIRST STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2020-12-10 4 M 0 967 0.00 A 5710 D Restricted Stock Units 2020-12-10 4 M 0 967 0.00 D 2020-12-10 Common Stock 967 967 D Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. The second out of three annual equal installments of restricted stock units vested on December 10, 2020. /s/ David Tyronne Howton, as Attorney-in-Fact for Mary Ann Gray 2020-12-10